PHENOTYPES OF POLYCYSTIC OVARY SYNDROME AND THEIR ASSOCIATION WITH METABOLIC SYNDROME- A NORTH INDIAN TERTIARY CARE CENTER BASED STUDY

Background PCOS (Polycystic Ovary Syndrome) is a widely recognized endocrine disorder of the reproductive age group. PCOS women are known to have insulin resistance and an increased tendency for weight gain, leading to an alteration in the metabolic prole. Objectives To categorize women diagnosed as PCOS into various phenotypes and study their correlation with metabolic syndrome. Methods A study was conducted in the department of Obstetrics and Gynecology, GMC Patiala from Jan 2019 to June 2020 and the PCOS were diagnosed and classied into 4 Phenotypes and prevalence of metabolic syndrome as per ATP III/ NCEP criteria was studied in various phenotypes. Results During the study period 116 patients were diagnosed as PCOS. The mean age of the PCOS cases was 24.86 ± 4.96 years (n=116). The PCOS Phenotype A had the maximum prevalence, 52.59%, followed by Phenotype B 18.97%, Phenotype D 16.38%, and Phenotype C 12.06%. The lipid prole was maximally deranged in Phenotype D. The metabolic syndrome was present in 26.72% of cases, with maximum cases belonging to Phenotype A. Conclusion The PCOS cases have a higher prevalence of deranged metabolic proles at a young age. An early multidisciplinary approach in PCOS cases is essential, to lower the prevalence of deranged metabolic prole and long term co-morbidities.

[1]  A. Aversa,et al.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions , 2020, Frontiers in Endocrinology.

[2]  F. Tosi,et al.  Insulin resistance and PCOS: chicken or egg? , 2020, Journal of Endocrinological Investigation.

[3]  N. Verma,et al.  Prevalence of metabolic syndrome among women with different PCOS phenotypes – a prospective study , 2020, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  A. Kazemnejad,et al.  Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study , 2020, International journal of reproductive biomedicine.

[5]  Yuan-jie Xie,et al.  Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[6]  N. Sachdeva,et al.  Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene , 2019, Indian journal of endocrinology and metabolism.

[7]  Aleide Tavares,et al.  The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome , 2019, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

[8]  V. Chandrasekharan,et al.  Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques , 2018, PloS one.

[9]  J. Spandana,et al.  A study on the clinical, biochemical and hormonal profile of polycystic ovary syndrome patients attending tertiary care hospital , 2017 .

[10]  R. Azziz,et al.  Criteria, prevalence, and phenotypes of polycystic ovary syndrome. , 2016, Fertility and sterility.

[11]  Saxena Pikee,et al.  Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome , 2016, The Journal of Obstetrics and Gynecology of India.

[12]  J. Qiao,et al.  Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS , 2015, Journal of Assisted Reproduction and Genetics.

[13]  F. Azizi,et al.  The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran , 2014, Reproductive Biology and Endocrinology.

[14]  Kristen A Pate,et al.  Epidemiology, diagnosis, and management of polycystic ovary syndrome. , 2013, Clinical epidemiology.

[15]  I. Katsikis,et al.  Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. , 2013, European journal of endocrinology.

[16]  R. Dȩbski,et al.  Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome , 2012, ISRN endocrinology.

[17]  M. Eijkemans,et al.  PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors , 2006, BJOG : an international journal of obstetrics and gynaecology.

[18]  S. Grundy.  Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[20]  A. Lanzone,et al.  A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. , 2001, Fertility and sterility.

[21]  E. Baracat,et al.  Polycystic Ovary Syndrome: Correlation between Phenotypes and Metabolic Syndrome , 2013 .